These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

323 related items for PubMed ID: 9127812

  • 1. Regional hemodynamic effects of candesartan cilexetil (TCV-116), an angiotensin II AT1-receptor antagonist, in conscious spontaneously hypertensive rats.
    Kanagawa R, Wada T, Sanada T, Ojima M, Inada Y.
    Jpn J Pharmacol; 1997 Mar; 73(3):185-90. PubMed ID: 9127812
    [Abstract] [Full Text] [Related]

  • 2. Comparison of the antihypertensive effects of the new angiotensin II (AT1) receptor antagonist candesartan cilexetil (TCV-116) and the angiotensin converting enzyme inhibitor enalapril in rats.
    Wada T, Inada Y, Ojima M, Sanada T, Shibouta Y, Nishikawa K.
    Hypertens Res; 1996 Jun; 19(2):75-81. PubMed ID: 10968199
    [Abstract] [Full Text] [Related]

  • 3. Renal responses to angiotensin receptor antagonist and angiotensin-converting enzyme inhibitor in partially nephrectomized spontaneously hypertensive rats.
    Okada H, Suzuki H, Kanno Y, Ikenaga H, Saruta T.
    J Cardiovasc Pharmacol; 1995 Oct; 26(4):564-9. PubMed ID: 8569216
    [Abstract] [Full Text] [Related]

  • 4. Protective effects of candesartan cilexetil (TCV-116) against stroke, kidney dysfunction and cardiac hypertrophy in stroke-prone spontaneously hypertensive rats.
    Inada Y, Wada T, Ojima M, Sanada T, Shibouta Y, Kanagawa R, Ishimura Y, Fujisawa Y, Nishikawa K.
    Clin Exp Hypertens; 1997 Oct; 19(7):1079-99. PubMed ID: 9310205
    [Abstract] [Full Text] [Related]

  • 5. Effects of candesartan cilexetil and enalapril on structural alterations and endothelial function in small resistance arteries of spontaneously hypertensive rats.
    Rizzoni D, Porteri E, Bettoni G, Piccoli A, Castellano M, Muiesan ML, Pasini G, Guelfi D, Rosei EA.
    J Cardiovasc Pharmacol; 1998 Nov; 32(5):798-806. PubMed ID: 9821855
    [Abstract] [Full Text] [Related]

  • 6. Effects of the non-peptide angiotensin II receptor antagonist TCV-116 on systemic and renal hemodynamics in dogs with renal hypertension.
    Ito K, Shiomi M, Kito G.
    Hypertens Res; 1995 Mar; 18(1):69-75. PubMed ID: 7584913
    [Abstract] [Full Text] [Related]

  • 7. Effect of an angiotensin II receptor antagonist, TCV-116, on cardiac hypertrophy and coronary circulation in spontaneously hypertensive rats.
    Takeda K, Fujita H, Nakamura K, Uchida A, Tanaka M, Itoh H, Nakata T, Sasaki S, Nakagawa M.
    Blood Press Suppl; 1994 Mar; 5():94-8. PubMed ID: 7889211
    [Abstract] [Full Text] [Related]

  • 8. Persistent cardiovascular effects of chronic renin-angiotensin system inhibition following withdrawal in adult spontaneously hypertensive rats.
    Paull JR, Widdop RE.
    J Hypertens; 2001 Aug; 19(8):1393-402. PubMed ID: 11518847
    [Abstract] [Full Text] [Related]

  • 9. Angiotensin II type 1 (AT1) receptor blockade in hypertensive women: benefits of candesartan cilexetil versus enalapril or hydrochlorothiazide.
    Malmqvist K, Kahan T, Dahl M.
    Am J Hypertens; 2000 May; 13(5 Pt 1):504-11. PubMed ID: 10826401
    [Abstract] [Full Text] [Related]

  • 10. Comparison of systemic and regional hemodynamic effects of a diuretic, an angiotensin II receptor antagonist, and an angiotensin-converting enzyme inhibitor in conscious renovascular hypertensive rats.
    Wang YX, Gavras I, Wierzba T, Gavras H.
    J Lab Clin Med; 1992 Mar; 119(3):267-72. PubMed ID: 1541876
    [Abstract] [Full Text] [Related]

  • 11. Acute effects of candesartan cilexetil (the new angiotensin II antagonist) on systemic and renal haemodynamics in hypertensive patients.
    Fridman K, Andersson OK, Wysocki M, Friberg P, Sunzel M.
    Eur J Clin Pharmacol; 1998 Sep; 54(7):497-501. PubMed ID: 9832289
    [Abstract] [Full Text] [Related]

  • 12. Comparable effects of angiotensin II and converting enzyme blockade on hemodynamics and cardiac hypertrophy in spontaneously hypertensive rats.
    Mori T, Nishimura H, Ueyama M, Kubota J, Kawamura K.
    Jpn Circ J; 1995 Sep; 59(9):624-30. PubMed ID: 7500546
    [Abstract] [Full Text] [Related]

  • 13. Effects of candesartan cilexetil (TCV-116) and enalapril in 5/6 nephrectomized rats.
    Noda M, Fukuda R, Matsuo T, Ohta M, Nagano H, Imura Y, Nishikawa K, Shibouta Y.
    Kidney Int Suppl; 1997 Dec; 63():S136-9. PubMed ID: 9407442
    [Abstract] [Full Text] [Related]

  • 14. Enalapril and losartan reduced cardiac mass and improved coronary hemodynamics in SHR.
    Nunez E, Hosoya K, Susic D, Frohlich ED.
    Hypertension; 1997 Jan; 29(1 Pt 2):519-24. PubMed ID: 9039153
    [Abstract] [Full Text] [Related]

  • 15. Comparative effects of candesartan and enalapril on augmented vasoconstrictive responses to endothelin-1 in coronary vessels of spontaneously hypertensive rats.
    Miki S, Takeda K, Hatta T, Harada S, Kido H, Oguni A, Moriguchi J, Morimoto S, Kawa T, Sasaki S, Nakagawa M.
    Am J Hypertens; 2002 Mar; 15(3):286-90. PubMed ID: 11939622
    [Abstract] [Full Text] [Related]

  • 16. High-dose, not low-dose insulin increases the vasoconstrictor effect of norepinephrine in spontaneously hypertensive rats: effects of antihypertensive treatment.
    Rizzoni D, Porteri E, Piccoli A, Castellano M, Pasini G, Guelfi D, Muiesan ML, Rosei EA.
    J Vasc Res; 1999 Mar; 36(5):393-403. PubMed ID: 10559680
    [Abstract] [Full Text] [Related]

  • 17. Clinical efficacy and tolerability of candesartan cilexetil. Candesartan Study Groups in Japan.
    Ogihara T, Arakawa K.
    J Hum Hypertens; 1999 Jan; 13 Suppl 1():S27-31; discussion S33-4. PubMed ID: 10076918
    [Abstract] [Full Text] [Related]

  • 18. Efficacy of SR 47436 (BMS-186295), a non-peptide angiotensin AT1 receptor antagonist in hypertensive rat models.
    Lacour C, Canals F, Galindo G, Cazaubon C, Segondy D, Nisato D.
    Eur J Pharmacol; 1994 Nov 03; 264(3):307-16. PubMed ID: 7698170
    [Abstract] [Full Text] [Related]

  • 19. Blockade of the renin-angiotensin system improves cerebral microcirculatory perfusion in diabetic hypertensive rats.
    Estato V, Obadia N, Carvalho-Tavares J, Freitas FS, Reis P, Castro-Faria Neto H, Lessa MA, Tibiriçá E.
    Microvasc Res; 2013 May 03; 87():41-9. PubMed ID: 23466285
    [Abstract] [Full Text] [Related]

  • 20. Combined blockade of AT1-receptors and ACE synergistically potentiates antihypertensive effects in SHR.
    Raasch W, Jöhren O, Schwartz S, Gieselberg A, Dominiak P.
    J Hypertens; 2004 Mar 03; 22(3):611-8. PubMed ID: 15076168
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.